Drug-induced convulsions. Report from Boston Collaborative Drug Surveillance Program.
D002746:Chlorpromazine / Q000009:adverse effects; D004809:Ephedrine / Q000009:adverse effects; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007275:Injections, Intravenous; D007328:Insulin / Q000009:adverse effects; D007538:Isoniazid / Q000009:adverse effects; D008012:Lidocaine / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010400:Penicillin G / Q000009:adverse effects; D010406:Penicillins / Q000009:adverse effects*; D010629:Phenformin / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects*; D011241:Prednisone / Q000009:adverse effects; D011346:Prochlorperazine / Q000009:adverse effects; D012640:Seizures / Q000139:chemically induced*; D010837:Vitamin K 1 / Q000009:adverse effects
D007004:Hypoglycemic Agents; D007328:Insulin; D010406:Penicillins; D010640:Phenothiazines; D010837:Vitamin K 1; D008012:Lidocaine; D010629:Phenformin; D004809:Ephedrine; D010400:Penicillin G; D002746:Chlorpromazine; D007538:Isoniazid; D011241:Prednisone; D011346:Prochlorperazine